true

Policies

Policies, Guidelines and Statements Center

Background Image
Page Policies
Filters
Clear

Filters

Browse Policies Icon
Browse All
Sort by :
Policy Name (A-Z)
Policy Name (A-Z) Policy Name (Z-A) Relevance Latest Oldest

Your search did not match any documents.
help-icon
Search Tips:
  • Click on the All tab to broaden your search across all BD.com content
  • Check the Knowledge Center for literature, case studies, events, or other documents
  • Explore our Products and Solutions
  • Search for related topics of interest using the search bar above, then try modifying your search using the filters at left
  • Check our Support pages or Contact Us
  • Try to search for similar words and pages
  • Check your spelling
Form

Corporate Policies

https://www.bd.com/en-us/about-bd/policies/clinical-trial-publication-policy

https://www.bd.com/en-no/company/trading-partners/bd-suppliers/corporate-policies-and-resources-for-suppliers

https://www.bd.com/en-no/company/about-bd/bd-values

Supplier Resources

The BD OnclarityTM HPV Assay can detect clinical levels of any target HPV type in the presence of up to one million copies of another competing type.

In other words, you won’t miss the less abundant HPV type(s) in your patients.10

The BD Onclarity™ HPV Assay is designed to provide you with the detailed results you need to better support patients with higher risk of disease.11 Detects 14 hr-HPV genotypes and reports up to 9 results6

  • Individual results for HPV genotypes with highest-risk for disease: 16, 18, 45, 31, 51 and 52
  • Strategic grouped results for lower risk HPV genotypes: 35/39/68, 33/58 and 56/59/66
true